Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in Kezar Life Sciences, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −1 vs. Q4 2024
- Shares held
- 4.33M
- +128.2K (+3.1%) vs. Q4 2024
- Total value
- $21.1M
- −$7.10M (−25.2%) vs. Q4 2024
- New holders
- 5
- 7 more added
- Sold out
- 6
- 14 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 1 | $5 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 4 | $20 | 0.00% | −465−99.1% | Reduced |
| Citigroup Inc | 51 | $249 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 100 | $402 | 0.00% | +100 | New |
| BNP Paribas Arbitrage, SA | 96 | $468 | 0.00% | −13−11.9% | Reduced |
| JPMorgan Chase & Co | 166 | $810 | 0.00% | −11,718−98.6% | Reduced |
| Bank of America Corp | 172 | $839 | 0.00% | +2+1.2% | Added |
| UBS Group AG | 2,040 | $9.96K | 0.00% | −12,800−86.3% | Reduced |
| Wells Fargo & Company | 5,703 | $27.8K | 0.00% | −474−7.7% | Reduced |
| Morgan Stanley | 7,211 | $35.2K | 0.00% | −13,398−65.0% | Reduced |
| Northern Trust Corp | 13,940 | $68.0K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 14,305 | $69.8K | 0.00% | +5,904+70.3% | Added |
| Clear Harbor Asset Management, LLC | 15,805 | $77.1K | 0.01% | +15,805 | New |
| Squarepoint Ops LLC | 20,299 | $99.1K | 0.00% | +20,299 | New |
| Boothbay Fund Management, LLC | 20,900 | $102.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,093 | $102.9K | 0.00% | 00.0% | Unchanged |
| Woodline Partners LP | 25,555 | $124.7K | 0.00% | +25,555 | New |
| Goldman Sachs Group Inc | 28,178 | $137.5K | 0.00% | −24,094−46.1% | Reduced |
| RBF Capital, LLC | 28,253 | $137.9K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 31,380 | $153.1K | 0.00% | −11,957−27.6% | Reduced |
| Two Sigma Investments, LP | 31,870 | $155.5K | 0.00% | −30,113−48.6% | Reduced |
| Dimensional Fund Advisors LP | 32,310 | $157.7K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 41,000 | $200.1K | 0.01% | +41,000 | New |
| Two Sigma Advisers, LP | 64,509 | $314.8K | 0.00% | −35,632−35.6% | Reduced |
| Shay Capital LLC | 67,511 | $329.5K | 0.10% | +8,353+14.1% | Added |
| Geode Capital Management, LLC | 67,564 | $329.8K | 0.00% | +994+1.5% | Added |
| BlackRock, Inc. | 82,614 | $403.2K | 0.00% | −241−0.3% | Reduced |
| Qiming U.S. Ventures Management, LLC | 82,871 | $404.4K | 1.75% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 85,584 | $417.6K | 0.00% | −2,101−2.4% | Reduced |
| Stonepine Capital Management, LLC | 100,000 | $488.0K | 0.57% | −10,000−9.1% | Reduced |
| Ikarian Capital, LLC | 106,901 | $521.7K | 0.17% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 108,473 | $529.3K | 0.13% | 00.0% | Unchanged |
| Peapod Lane Capital LLC | 124,427 | $607.2K | 0.68% | +433+0.3% | Added |
| Acadian Asset Management LLC | 133,525 | $650.0K | 0.00% | −12,141−8.3% | Reduced |
| ADAR1 Capital Management, LLC | 147,404 | $719.3K | 0.14% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 192,700 | $940.4K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 276,228 | $1.35M | 0.00% | +2,117+0.8% | Added |
| BML Capital Management, LLC | 408,138 | $1.99M | 1.61% | +359,470+738.6% | Added |
| Avidity Partners Management LP | 502,600 | $2.45M | 0.51% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 716,759 | $3.50M | 0.14% | 00.0% | Unchanged |
| Tang Capital Management LLC | 720,000 | $3.51M | 0.19% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −142,316−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −17,805−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −16,870−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −8,224−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,036−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |